Krystal Biotech (KRYS) Finished Goods (2023 - 2026)
Krystal Biotech (KRYS) posted quarterly Finished Goods of $9.4 million for Q2 2026, up 449.62% year-over-year from $1.7 million in Q2 2025, and down 24.26% on a QoQ basis from $12.4 million in Q1 2026.
Krystal Biotech (KRYS) Finished Goods (2023 - 2026) Analysis & Trends
Krystal Biotech has reported Finished Goods for 4 years, with the latest figure at $9.4 million in Q2 2026.
- Finished Goods for Q2 2026 came in at $9.4 million, up 449.62% year-over-year; the trailing twelve-month figure through Jun 2026 was $9.4 million (up 449.62% YoY), and the FY2025 annual result was $9.3 million, up 338.05% from the prior year.
- Finished Goods retreated to $9.4 million in Q2 2026, from $12.4 million in the prior quarter.
- Over five years, Finished Goods peaked at $12.4 million in Q1 2026 and troughed at $161000.0 in Q1 2024.
- A 4-year average of $4.9 million and a median of $3.2 million in 2024 frame the typical range for Finished Goods.
- The largest YoY upside for Finished Goods was 3563.35% in 2025 against a maximum downside of 4.03% in 2025.
- A 4-year view of Finished Goods shows it stood at $627000.0 in 2023, then surged by 239.07% to $2.1 million in 2024, then soared by 338.05% to $9.3 million in 2025, then climbed by 0.5% to $9.4 million in 2026.
- Per Business Quant data, the three most recent Finished Goods figures were $9.4 million in Q2 2026, $12.4 million in Q1 2026, and $9.3 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Krystal Biotech | 9.83 Bn | 8.99 Bn | 112.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.36 Mn |
| Mar 31, 2026 | 12.36 Mn |
| Dec 31, 2025 | 9.31 Mn |
| Sep 30, 2025 | 7.27 Mn |
| Jun 30, 2025 | 1.70 Mn |
| Mar 31, 2025 | 5.90 Mn |
| Dec 31, 2024 | 2.13 Mn |
| Sep 30, 2024 | 3.21 Mn |
| Jun 30, 2024 | 1.64 Mn |
| Mar 31, 2024 | 161,000.00 |
| Dec 31, 2023 | 627,000.00 |